COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 1092: Articles 10911-10920  | Next

Simulating the impact of vaccination rates on the initial stages of a COVID-19 outbreak in New Zealand (Aotearoa) with a stochastic model
Watson, L. M.
10.1101/2021.11.22.21266721 — Posted: 2021-11-24 Discussion: Onsite
In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens
Lamerton, R. E., Marcial Juarez, E., Faustini, S. E., Perez-Toledo, M. E., Goodall, M., Jossi, S. E., Newby, M. L., Chapple, I., Dietrich, T., Veenith, T., Shields, A. M., Harper, L., Henderson, I. R., Rayes, J., Wraith, D. C., Watson, S. P., Crispin, M., Drayson, M. T., Richter, A. G., Cunningham, A. F.
10.1101/2021.11.22.21266681 — Posted: 2021-11-24
The role of multi-generational household clusters in COVID-19 in England
Thelwall, S., Zaidi, A., Nsonwu, O., Rice, W., Chudasama, D., Lamagni, T., Dabrera, G.
10.1101/2021.11.22.21266540 — Posted: 2021-11-24
In Vitro Nasal Tissue Model for the Validation of Nasopharyngeal and Mid-turbinate Swabs for SARS-CoV-2 Testing
Hartigan, D. R., Adelfio, M., Shutt, M. E., Jones, S. M., Patel, S., Marchand, J. T., McGuinness, P. D., Buchholz, B. O., Ghezzi, C. E.
10.1101/2021.11.22.21266713 — Posted: 2021-11-24
Serological responses to COVID-19 booster vaccine in England
Ireland, G., Whitaker, H., Ladhani, S. N., Baawuah, F., Subbarao, V., Linley, E., Warrener, L., O'Brien, M., Whillock, C., Moss, P., Ramsay, M. E., Amirthalingam, G., Brown, K. E.
10.1101/2021.11.22.21266692 — Posted: 2021-11-24
Germany's low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study
Neuhauser, H., Schaffrath Rosario, A., Butschalowsky, H., Haller, S., Hoebel, J., Michel, J., Nitsche, A., Poethko-Mueller, C., Pruetz, F., Schlaud, M., Steinhauer, H. W., Wilking, H., Wieler, L. H., Schaade, L., Liebig, S., Goesswald, A., Grabka, M. M., Zinn, S., Ziese, T.
10.1101/2021.11.22.21266711 — Posted: 2021-11-24
Neutralization of SARS-CoV-2 variants by rVSV-ΔG-spike-elicited human sera
Yahalom-Ronen, Y., Erez, N., Fisher, M., Tamir, H., Politi, B., Achdout, H., Melamed, S., Glinert, I., Weiss, S., Cohen-Gihon, I., Israely, O., Izak, M., Mandelboim, M., Caraco, Y., Madar-Balakirski, N., Mechaly, A., Shinar, E., Cohen, D., Beth-Din, A., Zvi, A., Marcus, H., Israely, T., Paran, N.
10.1101/2021.11.22.21266673 — Posted: 2021-11-24
Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type
Dingemans, J., van der Veer, B. M. J. W., Gorgels, K. M. F., Hackert, V., Hensels, A. Y. J., den Heijer, C. D. J., Hoebe, C. J. P. A., Savelkoul, P. H. M., van Alphen, L. B.
10.1101/2021.11.22.21266676 — Posted: 2021-11-24
Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial
Holubar, M., Subramanian, A. K., Purington, N., Hedlin, H., Bunning, B., Walter, K., Bonilla, H., Boumis, A., Chen, M., Clinton, K., Dewhurst, L., Epstein, C., Jagannathan, P., Kaszynski, R., Panu, L., Parsonnet, J., Ponder, E., Quintero, O., Sefton, E., Singh, U., Soberanis, L., Truong, H., Andrews, J., Desai, M., Khosla, C., Maldonado, Y.
10.1101/2021.11.22.21266690 — Posted: 2021-11-24
Development and Evaluation of AccuPower(R) COVID-19 Multiplex Real-Time RT-PCR Kit and AccuPower(R) SARS-CoV-2 Multiplex Real-Time RT-PCR Kit for SARS-CoV-2 Detection in Sputum, NPS/OPS, Saliva and Pooled Samples
Suh, I. B., Lim, J., Kim, H. S., Rhim, G., Kim, H., Kim, H., Lee, S.-M., Park, H.-s., Song, H. J., Hong, M., Shin, G. S., Kim, M. J.
10.1101/2021.11.21.21264927 — Posted: 2021-11-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).